Effects of Nutrition on Post Stroke Fatigue

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Feb 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a nutritional supplement called SiderAL® Med on fatigue experienced by patients who have had a stroke. Fatigue after a stroke can be a challenging condition, making it hard for individuals to feel energized or motivated to engage in everyday activities. The trial aims to see if taking this supplement, which contains essential vitamins and minerals, can help improve both physical and mental tiredness in these patients.

To participate in this trial, individuals must be at least 5 years old and have experienced either an ischemic (caused by a blockage) or hemorrhagic (caused by bleeding) stroke within the last 1 to 6 months. They should also be able to walk independently or with minimal help and understand simple instructions. Participants will be monitored to see if the nutritional supplement helps reduce their fatigue and improves their overall energy levels. It’s important to note that certain health conditions and treatments may exclude someone from participating, so potential volunteers should discuss their eligibility with their healthcare provider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater than or equal to 5 years;
• • Patients with ischemic or haemorrhagic stroke outcomes documented through neuroimaging techniques (magnetic resonance or computed tomography);
• • Latency from the acute event between 1 and 6 months;
• • Cognitive skills that allow you to carry out simple orders and understand the physiotherapist's instructions \[assessed through the Token Test (score ≥ 26.5)\];
• • Ability to walk independently or with little assistance;
• • Ability to understand and sign informed consent.
• Exclusion Criteria:
• • Vitamin D intake greater than 3000 IU/day;
• • Therapy with Vitamin K antagonists;
• • Conditions causing excess electrolytes in the blood;
• • Diagnosis of metabolic mineral storage disorders (eg, hemochromatosis, Wilson);
• • Dialysis patients;
• • Systemic, neurological, cardiac pathologies that make walking risky or cause motor deficits;
• • Oncological pathologies;
• • Problems of an orthopedic or postural nature;
• • Presence of plantar ulcers;
• • Partial or total amputation of segments of the foot;
• • Inability to provide informed consent.